204 related articles for article (PubMed ID: 26485712)
1. High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.
Chen L; Yang L; Qiao F; Hu X; Li S; Yao L; Yang XL; Shao ZM
PLoS One; 2015; 10(10):e0140572. PubMed ID: 26485712
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.
Sun L; Shi C; Liu S; Zhang E; Yan L; Ji C; Zhao Y
Gene; 2020 Jul; 747():144657. PubMed ID: 32298762
[TBL] [Abstract][Full Text] [Related]
3. High NUSAP1 expression predicts poor prognosis in colon cancer.
Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
[TBL] [Abstract][Full Text] [Related]
4. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Thike AA; Tan PH; Ikeda M; Iqbal J
Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
[TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
6. A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
Shi M; Ma F; Liu J; Xing H; Zhu H; Yu J; Yang M
Breast Cancer Res Treat; 2017 Nov; 166(1):109-116. PubMed ID: 28744749
[TBL] [Abstract][Full Text] [Related]
7. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
8. Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Sharma P; Barlow WE; Godwin AK; Pathak H; Isakova K; Williams D; Timms KM; Hartman AR; Wenstrup RJ; Linden HM; Tripathy D; Hortobagyi GN; Hayes DF
Ann Oncol; 2018 Mar; 29(3):654-660. PubMed ID: 29293876
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.
Gui Y; Xu S; Yang X; Gu L; Zhang Z; Luo X; Chen L
Biomark Med; 2016 Jul; 10(7):771-90. PubMed ID: 27339713
[TBL] [Abstract][Full Text] [Related]
10. Subcellular expression of MTA1, HIF1A and p53 in primary tumor predicts aggressive triple negative breast cancers: a meta-analysis based study.
Sharaf SS; Jaganath Krishna KM; Lekshmi A; Sujathan
J Mol Histol; 2024 Jun; 55(3):303-315. PubMed ID: 38613589
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of cyclin D1 expression in patients with triple-negative breast cancer.
Bolat Kucukzeybek B; Vedat Bayoglu I; Kucukzeybek Y; Alacacioglu A; Yigit S; Akder Sari A; Akyol M; Oktay Tarhan M
J BUON; 2017; 22(4):947-952. PubMed ID: 28952212
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
[TBL] [Abstract][Full Text] [Related]
16. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
Jiang Y; Liu Y; Tan X; Yu S; Luo J
Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers.
Bignon L; Fricker JP; Nogues C; Mouret-Fourme E; Stoppa-Lyonnet D; Caron O; Lortholary A; Faivre L; Lasset C; Mari V; Gesta P; Gladieff L; Hamimi A; Petit T; Velten M
Breast J; 2018 May; 24(3):269-277. PubMed ID: 28929593
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC.
Ignatov T; Poehlmann A; Ignatov A; Schinlauer A; Costa SD; Roessner A; Kalinski T; Bischoff J
Breast Cancer Res Treat; 2013 Sep; 141(2):205-12. PubMed ID: 24026861
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients.
Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114
[TBL] [Abstract][Full Text] [Related]
20. DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers.
Abdel-Fatah TM; Arora A; Moseley PM; Perry C; Rakha EA; Green AR; Chan SY; Ellis IO; Madhusudan S
Oncotarget; 2015 Sep; 6(26):21964-78. PubMed ID: 26267318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]